Cencora (NYSE:COR) Upgraded to Hold at Royal Bank Of Canada

Posted by Brian Himes on Aug 20th, 2026

Royal Bank Of Canada upgraded shares of Cencora (NYSE:COR – Free Report) to a hold rating in a research report released on Wednesday, MarketBeat Ratings reports.

COR has been the topic of a number of other research reports. Citigroup reaffirmed a “buy” rating on shares of Cencora in a research report on Thursday, August 6th. Bank of America raised their price target on shares of Cencora from $280.00 to $285.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. Barclays dropped their price objective on shares of Cencora from $425.00 to $350.00 and set an “overweight” rating on the stock in a report on Wednesday, June 10th. William Blair started coverage on shares of Cencora in a research report on Tuesday, April 28th. They set a “market perform” rating for the company. Finally, Weiss Ratings upgraded shares of Cencora from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $370.85.

View Our Latest Report on Cencora

Cencora Price Performance

Shares of NYSE:COR opened at $316.78 on Wednesday. The business has a 50 day moving average price of $301.20 and a 200 day moving average price of $312.16. Cencora has a twelve month low of $244.82 and a twelve month high of $377.54. The company has a market cap of $60.45 billion, a price-to-earnings ratio of 23.53, a PEG ratio of 1.81 and a beta of 0.57. The company has a quick ratio of 0.58, a current ratio of 0.93 and a debt-to-equity ratio of 3.53.

Cencora (NYSE:COR – Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.35 by $0.13. Cencora had a return on equity of 125.45% and a net margin of 0.79%.The firm had revenue of $84.75 billion for the quarter, compared to analyst estimates of $84.31 billion. During the same quarter last year, the firm posted $4.00 EPS. The company’s revenue was up 5.1% on a year-over-year basis. Research analysts predict that Cencora will post 17.87 earnings per share for the current year.

Cencora Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Friday, August 14th will be paid a $0.60 dividend. The ex-dividend date is Friday, August 14th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.8%. Cencora’s dividend payout ratio is currently 17.83%.

Cencora declared that its board has approved a share repurchase program on Thursday, May 21st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the company to repurchase up to 3.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its shares are undervalued.

Insider Buying and Selling at Cencora

In other Cencora news, Director Lauren M. Tyler bought 550 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were acquired at an average price of $270.23 per share, with a total value of $148,626.50. Following the completion of the purchase, the director directly owned 4,359 shares in the company, valued at $1,177,932.57. The trade was a 14.44% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.38% of the company’s stock.

Institutional Investors Weigh In On Cencora

A number of institutional investors have recently added to or reduced their stakes in COR. Kemnay Advisory Services Inc. bought a new position in shares of Cencora during the 4th quarter worth approximately $25,000. Oakworth Capital Inc. acquired a new position in Cencora during the fourth quarter worth $26,000. Elyxium Wealth LLC acquired a new position in Cencora during the fourth quarter worth $27,000. Archer Investment Corp lifted its holdings in shares of Cencora by 134.3% during the fourth quarter. Archer Investment Corp now owns 82 shares of the company’s stock valued at $28,000 after acquiring an additional 47 shares during the period. Finally, Motiv8 Investments LLC acquired a new stake in shares of Cencora in the 4th quarter valued at $29,000. 97.52% of the stock is owned by institutional investors and hedge funds.

About Cencora

(Get Free Report)

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.